4-94252669-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2
The NM_020159.5(SMARCAD1):c.943A>G(p.Arg315Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000684 in 1,578,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020159.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMARCAD1 | NM_020159.5 | c.943A>G | p.Arg315Gly | missense_variant | 9/24 | ENST00000354268.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMARCAD1 | ENST00000354268.9 | c.943A>G | p.Arg315Gly | missense_variant | 9/24 | 1 | NM_020159.5 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000920 AC: 14AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000893 AC: 19AN: 212786Hom.: 0 AF XY: 0.000130 AC XY: 15AN XY: 115140
GnomAD4 exome AF: 0.0000659 AC: 94AN: 1426576Hom.: 0 Cov.: 32 AF XY: 0.0000791 AC XY: 56AN XY: 707534
GnomAD4 genome ? AF: 0.0000919 AC: 14AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74502
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.943A>G (p.R315G) alteration is located in exon 9 (coding exon 8) of the SMARCAD1 gene. This alteration results from a A to G substitution at nucleotide position 943, causing the arginine (R) at amino acid position 315 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at